H-Index & Metrics Best Publications

H-Index & Metrics

Discipline name H-index Citations Publications World Ranking National Ranking
Medicine D-index 116 Citations 77,774 485 World Ranking 1868 National Ranking 6

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Disease
  • Surgery

His primary scientific interests are in Physical therapy, Rheumatoid arthritis, Internal medicine, Arthritis and Rheumatology. His work deals with themes such as Clinical trial, Rheumatism, Ankylosing spondylitis, Disease and Evidence-based medicine, which intersect with Physical therapy. The various areas that Tore K Kvien examines in his Rheumatoid arthritis study include Connective tissue disease, Randomized controlled trial and Rituximab.

His research integrates issues of Gastroenterology, Placebo, Surgery and Placebo-controlled study in his study of Internal medicine. His work carried out in the field of Arthritis brings together such families of science as Physical disability, Severity of illness, Epidemiology and Quality of life. His studies deal with areas such as Erythrocyte sedimentation rate and Prospective cohort study as well as Rheumatology.

His most cited work include:

  • 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. (4441 citations)
  • Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis (3548 citations)
  • EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update (3425 citations)

What are the main themes of his work throughout his whole career to date?

Tore K Kvien mainly investigates Internal medicine, Rheumatoid arthritis, Physical therapy, Arthritis and Rheumatology. His Internal medicine research incorporates themes from Gastroenterology and Surgery. His Rheumatoid arthritis research incorporates elements of Severity of illness, Connective tissue disease and Disease.

His studies in Physical therapy integrate themes in fields like Clinical trial, Epidemiology, Randomized controlled trial, Quality of life and Ankylosing spondylitis. Arthritis is frequently linked to Visual analogue scale in his study. His Rheumatology study combines topics from a wide range of disciplines, such as Rheumatism and Synovitis.

He most often published in these fields:

  • Internal medicine (59.21%)
  • Rheumatoid arthritis (52.84%)
  • Physical therapy (33.91%)

What were the highlights of his more recent work (between 2018-2021)?

  • Internal medicine (59.21%)
  • Rheumatoid arthritis (52.84%)
  • In patient (14.80%)

In recent papers he was focusing on the following fields of study:

The scientist’s investigation covers issues in Internal medicine, Rheumatoid arthritis, In patient, Psoriatic arthritis and Physical therapy. His Internal medicine and Disease activity, Rheumatology, Disease, Observational study and Cohort investigations all form part of his Internal medicine research activities. The study incorporates disciplines such as Epidemiology, Discontinuation, Rituximab, Arthritis and Hazard ratio in addition to Rheumatoid arthritis.

His Arthritis research includes themes of Visual analogue scale, Severity of illness and Methotrexate. His Psoriatic arthritis study combines topics in areas such as Clinical trial and TNF inhibitor, Certolizumab pegol, Golimumab, Infliximab. His Physical therapy study combines topics from a wide range of disciplines, such as Osteoarthritis, Hand osteoarthritis and Intraclass correlation.

Between 2018 and 2021, his most popular works were:

  • EULAR recommendations for the management of psoriatic arthritis with pharmacological therapies: 2019 update (91 citations)
  • Long-term efficacy and safety of biosimilar infliximab (CT-P13) after switching from originator infliximab: open-label extension of the NOR-SWITCH trial (44 citations)
  • Long-term safety of certolizumab pegol in rheumatoid arthritis, axial spondyloarthritis, psoriatic arthritis, psoriasis and Crohn's disease: a pooled analysis of 11 317 patients across clinical trials. (19 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Disease
  • Surgery

His primary scientific interests are in Internal medicine, Rheumatoid arthritis, Psoriatic arthritis, In patient and Epidemiology. Many of his studies on Internal medicine involve topics that are commonly interrelated, such as Gastroenterology. He has included themes like Discontinuation, Arthritis, Proportional hazards model, Hazard ratio and Cohort in his Rheumatoid arthritis study.

His Arthritis study incorporates themes from TNF inhibitor, Longitudinal study, Observational study and Severity of illness. His Psoriatic arthritis research is multidisciplinary, relying on both Adverse effect, Clinical trial and Golimumab, Infliximab. His work is dedicated to discovering how Ankylosing spondylitis, Certolizumab pegol are connected with Rheumatism and other disciplines.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative.

Daniel Aletaha;Tuhina Neogi;Alan J. Silman;Julia Funovits.
Arthritis & Rheumatism (2010)

10141 Citations

Comparison of Upper Gastrointestinal Toxicity of Rofecoxib and Naproxen in Patients with Rheumatoid Arthritis

Claire Bombardier;Loren Laine;Alise Reicin;Deborah Shapiro.
The New England Journal of Medicine (2000)

5176 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update

Josef S Smolen;Robert Landewé;Ferdinand C Breedveld;Maya Buch;Maya Buch.
Annals of the Rheumatic Diseases (2014)

3425 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

J. S. Smolen;R. Landewé;F. C. Breedveld;M. Dougados.
Revmatologiia (2011)

3007 Citations

Treating rheumatoid arthritis to target: recommendations of an international task force

Josef S. Smolen;Daniel Aletaha;Johannes W J W Bijlsma;Ferdinand C Breedveld.
Annals of the Rheumatic Diseases (2010)

2471 Citations

EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs

Josef S. Smolen;Robert Landewé;Ferdinand C Breedveld;Maxime Dougados.
Annals of the Rheumatic Diseases (2010)

2195 Citations

EULAR evidence-based recommendations for cardiovascular risk management in patients with rheumatoid arthritis and other forms of inflammatory arthritis

M J Peters;D P M Symmons;D McCarey;B A Dijkmans.
Annals of the Rheumatic Diseases (2010)

1883 Citations

American College of Rheumatology/European League Against Rheumatism Provisional Definition of Remission in Rheumatoid Arthritis for Clinical Trials

David T. Felson;David T. Felson;Josef S. Smolen;George Wells;Bi Zhang.
Arthritis & Rheumatism (2011)

1541 Citations

Treating rheumatoid arthritis to target: 2014 update of the recommendations of an international task force

Josef S Smolen;Ferdinand C Breedveld;Gerd R Burmester;Vivian Bykerk.
Annals of the Rheumatic Diseases (2016)

1121 Citations

Efficacy and safety of leflunomide compared with placebo and sulphasalazine in active rheumatoid arthritis: a double-blind, randomised, multicentre trial

Josef S Smolen;Joachim R Kalden;David L Scott;Blaz Rozman.
The Lancet (1999)

1053 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Tore K. Kvien

Paul Emery

Paul Emery

University of Leeds

Publications: 325

Désirée van der Heijde

Désirée van der Heijde

Leiden University Medical Center

Publications: 248

Maxime Dougados

Maxime Dougados

Hôpital Cochin

Publications: 245

Josef S. Smolen

Josef S. Smolen

Medical University of Vienna

Publications: 214

Laure Gossec

Laure Gossec

Sorbonne University

Publications: 203

Robert Landewé

Robert Landewé

University of Amsterdam

Publications: 192

Mikkel Østergaard

Mikkel Østergaard

University of Copenhagen

Publications: 189

Philip J. Mease

Philip J. Mease

University of Washington

Publications: 173

Yoshiya Tanaka

Yoshiya Tanaka

University of Occupational and Environmental Health Japan

Publications: 164

Tom W. J. Huizinga

Tom W. J. Huizinga

Leiden University Medical Center

Publications: 146

Bernard Combe

Bernard Combe

University of Montpellier

Publications: 141

Bruno Fautrel

Bruno Fautrel

Université Paris Cité

Publications: 140

Vibeke Strand

Vibeke Strand

Stanford University

Publications: 136

Tsutomu Takeuchi

Tsutomu Takeuchi

Keio University

Publications: 133

Georg Schett

Georg Schett

University of Erlangen-Nuremberg

Publications: 126

Daniel Aletaha

Daniel Aletaha

Medical University of Vienna

Publications: 125

Something went wrong. Please try again later.